🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 30 Days
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(2118)
All (2118)
Buys (184)
Sells (1934)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
ABBOTT LABORATORIES
(ABT)
Cushman Elizabeth C.
— EVP, GC AND SECRETARY
Mar 2, 2026
Sale
Shares
263
Price
$115.58
Total Value
$30.40K
Shares Held After
38,573
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AGIOS PHARMACEUTICALS, INC.
(AGIO)
Gheuens Sarah
— Chief Medical Officer
Mar 2, 2026
Sale
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
74,406
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AGIOS PHARMACEUTICALS, INC.
(AGIO)
Gheuens Sarah
— Chief Medical Officer
Mar 2, 2026
Sale
Shares
1,681
Price
$28.96
Total Value
$48.68K
Shares Held After
71,593
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AGIOS PHARMACEUTICALS, INC.
(AGIO)
Gheuens Sarah
— Chief Medical Officer
Mar 2, 2026
Sale
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
67,608
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
American Well Corporation
(AMWL)
Gotlib Phyllis
— President, International
Mar 2, 2026
Sale
Shares
3,573
Price
$5.24
Total Value
$18.72K
Shares Held After
116,297
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Maze Therapeutics, Inc.
(MAZE)
Bachrodt Amy
— SVP, Finance
Mar 2, 2026
Sale
Shares
3,700
Price
$45.47
Total Value
$168.24K
Shares Held After
12,965
% of Holdings
22.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Maze Therapeutics, Inc.
(MAZE)
Bachrodt Amy
— SVP, Finance
Mar 2, 2026
Sale
Shares
1,300
Price
$44.44
Total Value
$57.77K
Shares Held After
16,665
% of Holdings
7.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ABBOTT LABORATORIES
(ABT)
MCCOY JOHN A. JR.
— VICE PRESIDENT AND CONTROLLER
Mar 2, 2026
Sale
Shares
585
Price
$115.58
Total Value
$67.61K
Shares Held After
24,628
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Delcath Systems, Inc.
(DCTH)
MICHEL GERARD J
— Director
Mar 2, 2026
Purchase
Shares
11,200
Price
$8.96
Total Value
$100.31K
Shares Held After
342,034
% of Holdings
3.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NovoCure Limited
(NVCR)
Leonard Frank X
— Chief Executive Officer
Mar 2, 2026
Sale
Shares
7,232
Price
$13.49
Total Value
$97.58K
Shares Held After
349,400
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
Ofman Joshua J.
— President
Mar 2, 2026
Sale
Shares
16,223
Price
$50.09
Total Value
$812.53K
Shares Held After
436,508
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
Ofman Joshua J.
— President
Mar 2, 2026
Sale
Shares
779
Price
$51.75
Total Value
$40.31K
Shares Held After
452,731
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alector, Inc.
(ALEC)
Berkley Neil Lindsay
— CFO & Chief Business Officer
Mar 2, 2026
Sale
Shares
29,649
Price
$2.12
Total Value
$62.95K
Shares Held After
344,660
% of Holdings
7.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CVRx, Inc.
(CVRX)
OASHEIM JARED
— CHIEF FINANCIAL OFFICER
Mar 2, 2026
Sale
Shares
1,744
Price
$7.90
Total Value
$13.78K
Shares Held After
96,703
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AGIOS PHARMACEUTICALS, INC.
(AGIO)
Jones Cecilia
— Chief Financial Officer
Mar 2, 2026
Sale
Shares
1,573
Price
$28.96
Total Value
$45.55K
Shares Held After
49,328
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AGIOS PHARMACEUTICALS, INC.
(AGIO)
Jones Cecilia
— Chief Financial Officer
Mar 2, 2026
Sale
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
45,598
% of Holdings
2.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AGIOS PHARMACEUTICALS, INC.
(AGIO)
Jones Cecilia
— Chief Financial Officer
Mar 2, 2026
Sale
Shares
1,681
Price
$28.96
Total Value
$48.68K
Shares Held After
42,785
% of Holdings
3.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AGIOS PHARMACEUTICALS, INC.
(AGIO)
Jones Cecilia
— Chief Financial Officer
Mar 2, 2026
Sale
Shares
594
Price
$28.96
Total Value
$17.20K
Shares Held After
38,800
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
40
Price
$525.28
Total Value
$21.01K
Shares Held After
130
% of Holdings
23.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
160
Price
$524.04
Total Value
$83.85K
Shares Held After
170
% of Holdings
48.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
379
Price
$523.19
Total Value
$198.29K
Shares Held After
330
% of Holdings
53.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
300
Price
$522.14
Total Value
$156.64K
Shares Held After
709
% of Holdings
29.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
420
Price
$521.07
Total Value
$218.85K
Shares Held After
1,009
% of Holdings
29.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
239
Price
$520.05
Total Value
$124.29K
Shares Held After
1,429
% of Holdings
14.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
319
Price
$518.97
Total Value
$165.55K
Shares Held After
1,668
% of Holdings
16.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
598
Price
$517.85
Total Value
$309.68K
Shares Held After
1,987
% of Holdings
23.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
872
Price
$517.02
Total Value
$450.84K
Shares Held After
2,585
% of Holdings
25.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
768
Price
$515.99
Total Value
$396.28K
Shares Held After
3,457
% of Holdings
18.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
1,064
Price
$515.15
Total Value
$548.12K
Shares Held After
4,225
% of Holdings
20.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
1,042
Price
$514.02
Total Value
$535.61K
Shares Held After
5,289
% of Holdings
16.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
1,360
Price
$512.83
Total Value
$697.45K
Shares Held After
6,331
% of Holdings
17.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
722
Price
$511.95
Total Value
$369.63K
Shares Held After
7,691
% of Holdings
8.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
311
Price
$511.05
Total Value
$158.94K
Shares Held After
8,413
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
427
Price
$509.66
Total Value
$217.63K
Shares Held After
8,724
% of Holdings
4.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
319
Price
$508.49
Total Value
$162.21K
Shares Held After
9,151
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 2, 2026
Sale
Shares
160
Price
$507.27
Total Value
$81.16K
Shares Held After
9,470
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Arcutis Biotherapeutics, Inc.
(ARQT)
Burnett Patrick
— Reporting Person's title: EVP, Chief Medical Officer
Mar 2, 2026
Sale
Shares
181
Price
$25.91
Total Value
$4.69K
Shares Held After
121,150
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Arcutis Biotherapeutics, Inc.
(ARQT)
Burnett Patrick
— Reporting Person's title: EVP, Chief Medical Officer
Mar 2, 2026
Sale
Shares
6,106
Price
$25.16
Total Value
$153.63K
Shares Held After
121,295
% of Holdings
4.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ultragenyx Pharmaceutical Inc.
(RARE)
Pinion John Richard
— EVP, Chief Quality Operations Officer
Mar 2, 2026
Sale
Shares
10,029
Price
$22.80
Total Value
$228.66K
Shares Held After
110,026
% of Holdings
8.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Karyopharm Therapeutics Inc.
(KPTI)
Rangwala Reshma
— EVP & Chief Medical Officer
Mar 2, 2026
Sale
Shares
5,066
Price
$9.41
Total Value
$47.67K
Shares Held After
56,739
% of Holdings
8.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CVRx, Inc.
(CVRX)
John Robert Allen
— Chief Revenue Officer
Mar 2, 2026
Sale
Shares
3,964
Price
$7.90
Total Value
$31.33K
Shares Held After
86,036
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Edesa Biotech, Inc.
(EDSA)
Nijhawan Pardeep
— Director
Mar 2, 2026
Purchase
Shares
1,000
Price
$2.28
Total Value
$2.28K
Shares Held After
372,702
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Edesa Biotech, Inc.
(EDSA)
Nijhawan Pardeep
— Director
Mar 2, 2026
Purchase
Shares
2,000
Price
$2.00
Total Value
$4.00K
Shares Held After
627,813
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Moderna, Inc.
(MRNA)
Klinger Shannon Thyme
— Chief Legal Officer
Mar 2, 2026
Sale
Shares
13,885
Price
$52.29
Total Value
$726.05K
Shares Held After
59,689
% of Holdings
18.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Beta Bionics, Inc.
(BBNX)
Hopman Mark
— Chief Commercial Officer
Mar 2, 2026
Sale
Shares
834
Price
$12.36
Total Value
$10.31K
Shares Held After
139,486
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
iRhythm Holdings, Inc.
(IRTC)
Shrishrimal Sumi
— EVP, Chief Risk Officer
Mar 2, 2026
Sale
Shares
978
Price
$128.44
Total Value
$125.62K
Shares Held After
41,870
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
iRhythm Holdings, Inc.
(IRTC)
Shrishrimal Sumi
— EVP, Chief Risk Officer
Mar 2, 2026
Sale
Shares
906
Price
$128.44
Total Value
$116.37K
Shares Held After
42,848
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
iRhythm Holdings, Inc.
(IRTC)
Shrishrimal Sumi
— EVP, Chief Risk Officer
Mar 2, 2026
Sale
Shares
946
Price
$128.44
Total Value
$121.50K
Shares Held After
43,754
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bausch Health Companies Inc.
(BHC)
Carson Seana
— EVP, General Counsel
Mar 2, 2026
Sale
Shares
6,856
Price
$5.78
Total Value
$39.63K
Shares Held After
776,076
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Beta Bionics, Inc.
(BBNX)
Russell Steven Jon
— Chief Medical Officer
Mar 2, 2026
Sale
Shares
1,026
Price
$12.36
Total Value
$12.68K
Shares Held After
179,096
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 1551–1600 of 2118 transactions (page 32 of 43)
Version: v26.3.33